Overview
Eugenia Haralambieva practices practicing medicine in Zurich, Switzerland.
Her clinical expertise encompasses T-Cell Lymphoma, Non-Hodgkin Lymphoma, Dendritic Cell Tumor, and Reticulohistiocytoma.
She is actively involved in clinical research, co-authoring 28 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Eugenia Haralambieva
Is Eugenia Haralambieva a top-rated expert for T-Cell Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Eugenia Haralambieva is classified as an Experienced expert for T-Cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Eugenia Haralambieva participate in research or clinical trials?
Yes. Eugenia Haralambieva has published 28 articles and abstracts on conditions like T-Cell Lymphoma. You can view a list of Eugenia Haralambieva's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Anaplastic Large Cell LymphomaMs. Haralambieva isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Arachnoid CystsMs. Haralambieva isExperienced. Learn about Arachnoid Cysts.
- Autoimmune Hemolytic AnemiaMs. Haralambieva isExperienced. Learn about Autoimmune Hemolytic Anemia.
- B-Cell LymphomaMs. Haralambieva isExperienced. Learn about B-Cell Lymphoma.
- Cutaneous T-Cell Lymphoma (CTCL)Ms. Haralambieva isExperienced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Dendritic Cell TumorMs. Haralambieva isExperienced. Learn about Dendritic Cell Tumor.
- Diffuse Large B-Cell Lymphoma (DLBCL)Ms. Haralambieva isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Erdheim-Chester DiseaseMs. Haralambieva isExperienced. Learn about Erdheim-Chester Disease.
- HistiocytosisMs. Haralambieva isExperienced. Learn about Histiocytosis.
- Langerhans Cell HistiocytosisMs. Haralambieva isExperienced. Learn about Langerhans Cell Histiocytosis.
- Lymphofollicular HyperplasiaMs. Haralambieva isExperienced. Learn about Lymphofollicular Hyperplasia.
- MeaslesMs. Haralambieva isExperienced. Learn about Measles.
- MononucleosisMs. Haralambieva isExperienced. Learn about Mononucleosis.
- MumpsMs. Haralambieva isExperienced. Learn about Mumps.
- Mycosis FungoidesMs. Haralambieva isExperienced. Learn about Mycosis Fungoides.
- Non-Hodgkin LymphomaMs. Haralambieva isExperienced. Learn about Non-Hodgkin Lymphoma.
- ReticulohistiocytomaMs. Haralambieva isExperienced. Learn about Reticulohistiocytoma.
- RubellaMs. Haralambieva isExperienced. Learn about Rubella.
- T-Cell LymphomaMs. Haralambieva isExperienced. Learn about T-Cell Lymphoma.
- Togaviridae DiseaseMs. Haralambieva isExperienced. Learn about Togaviridae Disease.
- WartsMs. Haralambieva isExperienced. Learn about Warts.